Celldex Therapeutics (CLDX) EBT Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Celldex Therapeutics (CLDX) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 6,691.00 |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -2,054.00 |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 8,006.00 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 9,980.00 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | -5,319.00 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,363.00 |
| 10 | Celldex Therapeutics | 3.08 Bn | 3.08 Bn | -2.57 Mn | -32.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.17 Mn |
| Mar 31, 2026 | -56.70 Mn |
| Dec 31, 2025 | -6.56 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 425,648.00 |
| Dec 31, 2024 | 202,451.00 |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | -148,846.00 |
| Mar 31, 2024 | -2.43 Mn |
| Dec 31, 2023 | -44,507.00 |
| Sep 30, 2023 | -39,274.00 |
| Jun 30, 2023 | -763,819.00 |
| Mar 31, 2023 | -279,620.00 |
| Dec 31, 2022 | -46,431.00 |
| Sep 30, 2022 | -449,054.00 |
| Jun 30, 2022 | -2.04 Mn |
| Mar 31, 2022 | -1.20 Mn |
| Dec 31, 2021 | -549,929.00 |
| Sep 30, 2021 | -1.27 Mn |
| Jun 30, 2021 | 20,953.00 |